Suven Life Sciences Limited (BOM: 530239)

Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	33,354	21,742	10,570	13,484	8,961	2,724
Market Cap Growth	65.59%	105.69%	-21.61%	50.48%	228.97%	-91.80%
Enterprise Value	30,963	19,776	10,468	13,313	8,934	2,406
Last Close Price	152.95	99.70	48.47	85.47	64.87	19.72
PE Ratio	-	-20.68	-7.31	-9.44	-11.44	-2.66
PS Ratio	374.00	185.94	77.75	112.83	63.67	18.52
PB Ratio	12.35	8.05	2.82	14.02	8.30	1.90
P/FCF Ratio	-	-18.83	-8.89	-9.15	-8.76	-1.99
P/OCF Ratio	-	-18.83	-9.11	-10.57	-9.33	-2.02
EV/Sales Ratio	230.55	169.13	77.00	111.40	63.48	16.36
EV/EBITDA Ratio	-15.68	-15.39	-8.29	-10.85	-11.20	-2.08
EV/EBIT Ratio	-15.02	-14.73	-7.93	-10.55	-10.73	-2.01
EV/FCF Ratio	-	-17.13	-8.81	-9.04	-8.73	-1.76
Debt / Equity Ratio	0.00	0.00	0.00	0.03	0.04	0.04
Debt / FCF Ratio	-	-0.01	-0.01	-0.02	-0.05	-0.04
Asset Turnover	-	0.03	0.05	0.10	0.09	0.06
Inventory Turnover	-	2.30	27.66	9.10	0.26	0.09
Quick Ratio	-	18.00	21.03	7.13	3.42	0.68
Current Ratio	-	18.99	22.61	8.01	6.45	2.49
Return on Equity (ROE)	-	-32.56%	-50.17%	-119.51%	-57.41%	-49.27%
Return on Assets (ROA)	-	-24.91%	-33.21%	-66.72%	-33.54%	-30.77%
Return on Capital (ROIC)	-26.37%	-25.92%	-34.65%	-74.38%	-39.72%	-38.17%
Earnings Yield	-3.28%	-4.83%	-11.19%	-9.05%	-8.05%	-34.59%
FCF Yield	-5.31%	-11.25%	-10.92%	-11.42%	-50.28%
Dividend Yield	0.00%	-	-	1.17%	-	-
Buyback Yield / Dilution	-10.71%	-22.31%	-32.29%	-5.88%	-	-
Total Shareholder Return	-10.71%	-22.31%	-32.29%	-4.71%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.